In a landmark investigation that addresses a well-known neurological disorder that affects more than 10 million people worldwide, the randomized double-blind, placebo-controlled study realized dramatic improvements in critical disease-conditions such as pain, facial expression, speech, handwriting, tremors, rigidity and falling.
January 31, 2019
· 1 min read